Clinical trial I7W-MC-JQBA
A Phase 1 Study of LY3127804 as Monotherapy and in Combination with Ramucirumab in Patients with Advanced Solid Tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2015-001204-64 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02597036 |
| Inclusion criteria | RECIST 1.1 after standard trerapy |
| Last update |